Sandeep Grewal in Flint, Michigan

Home Michigan Flint

Sandeep Grewal has Hematology/oncology as his primary medical specialty. Their primary office is: 4100 Beecher Rd in Flint, Michigan.

They're a part of the: Mclaren Flint medical group which has around 141 members. You can call their office at 810-342-3800 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2002 (around 22 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Sandeep S Grewal Office Phone and Directions

Sandeep Grewal
Mclaren Flint
4100 Beecher Rd
Flint, Michigan 48532
810-342-3800

Patient Ratings
Please rate your experience with Sandeep Grewal below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 810-342-3800

Enter a starting address:

Healthcare Info for Sandeep Grewal

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2002
The Primary Medical Specialty for Sandeep Grewal is listed as: Hematology/oncology
Approximate Years of Experience: 22
PAC (PECOS ID)#: 8426129222
NPI #: 1932315124
NPI Created On: 05/15/2007
NPI Last Updated Listed as: 09/25/2013
Primary Taxonomy Code: 207RH0003X
License Number:
4301085206
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
McLaren Health Plan Community
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of different chemotherapy drug or substance into a vein
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788837017

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788837019

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RYBREVANT

Name Of Drug #3: 57894-501-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788837021

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781010751

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818679343

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832178385

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783725723

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783725739

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ABECMA

Open Associated Drug #1: 59572-515-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783634279

Being Disputed:: No

Product Related: No

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 841906761

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology/Endocrinology

Name of Drug #1: SOMATULINE DEPOT

Open Associated Drug #1: 15054-0060-1

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: ONIVYDE

Associated Drug #2: 15054-0043-1

Hematology/oncology Professionals in Flint

1.
David Eilender MD

401 S Ballenger Hwy
Flint, MI
Mclaren Flint

2.
David Eilender MD

4100 Beecher Rd
Flint, MI
Mclaren Flint

3.
Tolutope Oyasiji

401 S Ballenger Hwy
Flint, MI
Mclaren Flint

4.
Tolutope Oyasiji

4100 Beecher Rd
Flint, MI
Mclaren Flint

5.
Rizwan Danish MD

302 Kensington Ave
Flint, MI

6.
Mohamad Khoulani MD

5080 Villa Linde Pkwy
Flint, MI

Providers in Mclaren Flint

1.Wafa Abbud Md

401 S Ballenger Hwy
Flint Mi 48532-3638
Mclaren Flint
Internal Medicine

2.Nazem Abdelfattah

G3230 Beecher Rd
Flint Mi 48532-3604
Mclaren Flint
Family Practice

3.Ebrahim Abdelrazzak

401 S Ballenger Hwy
Flint Mi 48532-3638
Mclaren Flint
Internal Medicine

4.Ebrahim Abdelrazzak

401 S Ballenger Hwy
Flint Mi 48532-3685
Mclaren Flint
Internal Medicine

5.Ahmed Abdullah

2487 N Elms Rd
Flushing Mi 48433-9426
Mclaren Flint
Obstetrics/gynecology

6.Oyebimpe Adekolujo

G3230 Beecher Rd
Flint Mi 48532-3604
Mclaren Flint
Geriatric Medicine

View all 141 members of Mclaren Flint medical group